Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Opioid treatment of pain is generally safe with 0.5% or less events from respiratory depression. However, fatalities are regularly reported. The only treatment currently available to reverse opioid respiratory depression is by naloxone infusion. The efficacy of naloxone depends on its own pharmacological characteristics and on those (including receptor kinetics) of the opioid that needs reversal. Short elimination of naloxone and biophase equilibration half-lives and rapid receptor kinetics complicates reversal of high-affinity opioids. An opioid with high receptor affinity will require greater naloxone concentrations and/or a continuous infusion before reversal sets in compared with an opioid with lower receptor affinity. The clinical approach to severe opioid-induced respiratory depression is to titrate naloxone to effect and continue treatment by continuous infusion until chances for renarcotization have diminished. New approaches to prevent opioid respiratory depression without affecting analgesia have led to the experimental application of serotinine agonists, ampakines, and the antibiotic minocycline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As previously proposed for other potent opioids (Amaducci et al., 2023; Bilel et al., 2022; Dahan et al., 2010; Klebacher et al., 2017), repeated naloxone dosing may be required to avoid re-narcotization.”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Dahan et al., 2010
In the citing paper
“Changes in RR and BL were fully blocked after naloxone pretreatment for all analogues (excluding iodorphine), confirming the involvement of opioid receptors (particularly MOR) in these actions (Bilel et al., 2022; Dahan et al., 2010).”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Dahan et al., 2010
In the citing paper
“Hence, the potency and intrinsic efficacy of MOR agonists may influence the observed effects after naloxone pretreatment (Bilel et al., 2023; Dahan et al., 2010; Nakamura et al., 2020; van Lemmen et al., 2023; Volpe et al., 2011), as also seen with fentanyl analogues (Bilel et al., 2023, 2022; Varshneya et al., 2023).”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Dahan et al., 2010
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Pre-Bötzinger Complex: a Brainstem Region that May Generate Respiratory Rhythm in Mammals
Smith, J. C., Ellenberger, H. H., Ballanyi, K., Richter, D. W., & Feldman, J. L. (1991) · Science · doi:10.1126/science.1683005 · Cited by 2,175
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Looking for inspiration: new perspectives on respiratory rhythm
Feldman, J. L., & Del Negro, C. A. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1871 · Cited by 846
Opioids and the control of respiration
Pattinson, K. T. S. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen094 · Cited by 793 · cited 1×
“The inhibition of this dynamic respiratory control system by opioids has been reviewed recently.(70) Respiratory drive may be restored by manipulation of neuronal transmitter systems in those regions, particularly serotinergic systems.”
BackgroundIonotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788 · cited 3×
“collectively called ampakines, examples of which are CX516, CX546, CX614, and CX717.(96,101) The AMPA receptor is”
BackgroundRekling, J. C., & Feldman, J. L. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.385 · Cited by 583
Pronounced, Episodic Oxygen Desaturation in the Postoperative Period
Catley, D. M., Thornton, C., Jordan, C., Lehane, J. R., Royston, D., & Jones, J. G. (1985) · Anesthesiology · doi:10.1097/00000542-198507000-00004 · Cited by 426 · cited 2×
“Definitions of what levels may constitute respiratory depression, however, will vary between practices or studies (e.g., Catley et al.16 who used SpO2 level of 80%).”
MethodDistinct rhythm generators for inspiration and expiration in the juvenile rat
Janczewski, W. A., & Feldman, J. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.098848 · Cited by 403
Buprenorphine: A Review of its Pharmacological Properties and Therapeutic Efficacy
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1979) · Drugs · doi:10.2165/00003495-197917020-00001 · Cited by 398
Measured Context-sensitive Half-times of Remifentanil and Alfentanil
Kapila, A., Glass, P. S. A., Jacobs, J. R., Muir, K. T., Hermann, D. J., Shiraishi, M., Howell, S., & Smith, R. L. (1995) · Anesthesiology · doi:10.1097/00000542-199511000-00009 · Cited by 393
Hutchinson, M. R., Bland, S. T., Johnson, K. W., Rice, K. C., Maier, S. F., & Watkins, L. R. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.230 · Cited by 359 · cited 1×
“Conversely, inhibitors of glial activation have been shown to enhance the analgesic efficacy of acute and chronic morphine.(111) A recent study has investigated whether minocycline, a tetracyclinederivative and an inhibitor of microglial activation,(112) may also influence opioid-induced respiratory depression as well…”
BackgroundFunk, G. D., Smith, J. C., & Feldman, J. L. (1993) · Journal of Neurophysiology · doi:10.1152/jn.1993.70.4.1497 · Cited by 334
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats
Dahan, A., Yassen, A., Bijl, H., Romberg, R., Sarton, E., Teppema, L., Olofsen, E., & Danhof, M. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei145 · Cited by 326 · cited 5×
“sion exhibits an apparent maximum or ceiling effect typical for a partial agonist at the !-opioid receptor.(11) However, the”
BackgroundInfluentialSelf-citationCashman, J. N., & Dolin, S. J. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh180 · Cited by 316 · cited 1×
“In a metaanalysis of intramuscular, epidural, and intravenous analgesia (including patient-controlled analgesia [PCA]), the incidence of opioid-induced respiratory depression as defined by low-breathing frequency was less than 1%.(18) Most of the studies included were designed to compare analgesic effects, but respira…”
BackgroundSacerdote, P. (2006) · Palliative Medicine · doi:10.1191/0269216306pm1124oa · Cited by 291
Pharmacokinetics of Naloxone in Rats and in Man: Basis for Its Potency and Short Duration of Action
Ngai, S. H., Berkowitz, B. A., Yang, J. C., Hempstead, J., & Spector, S. (1976) · Anesthesiology · doi:10.1097/00000542-197605000-00008 · Cited by 287 · cited 1×
“After intravenous infusion, approximately 70% is excreted through the kidney as conjugated naloxone metabolites and 30% as unchanged naloxone.(40) The extent and duration of naloxone-induced reversal of opioid-induced respiratory effects is highly variable and related to many factors, including the specific opioid use…”
BackgroundRespiratory rhythm generation in neonatal and adult mammals: the hybrid pacemaker–network model
Smith, J. C., Butera, R. J., Koshiya, N., Del Negro, C., Wilson, C. G., & Johnson, S. M. (2000) · Respiration Physiology · doi:10.1016/s0034-5687(00)00155-9 · Cited by 277
5-HT 4(a) Receptors Avert Opioid-Induced Breathing Depression Without Loss of Analgesia
Manzke, T., Guenther, U., Ponimaskin, E. G., Haller, M., Dutschmann, M., Schwarzacher, S., & Richter, D. W. (2003) · Science · doi:10.1126/science.1084674 · Cited by 276
Greer, J. J., Smith, J. C., & Feldman, J. L. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018622 · Cited by 252 · cited 1×
“of AMPA sites results in an inhibition of respiration and their enhancement leads to increases in respiratory frequency.(99)”
BackgroundMechanism of Positive Allosteric Modulators Acting on AMPA Receptors
Jin, R., Clark, S., Weeks, A. M., Dudman, J. T., Gouaux, E., & Partin, K. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2567-05.2005 · Cited by 245 · cited 1×
“further define the allosteric binding site and actions of the ampakines.(105) Actions within the pre-Bötzinger complex,”
BackgroundPatient-Controlled Analgesia in the Management of Postoperative Pain
Momeni, M., Crucitti, M., & De Kock, M. (2006) · Drugs · doi:10.2165/00003495-200666180-00005 · Cited by 228
AMPA Receptor Potentiators for the Treatment of CNS Disorders
O'Neill, M., Bleakman, D., Zimmerman, D., & Nisenbaum, E. (2004) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007043337508 · Cited by 223 · cited 2×
“collectively called ampakines, examples of which are CX516, CX546, CX614, and CX717.(96,101) The AMPA receptor is”
BackgroundRespiratory depression associated with patient-controlled analgesia: a review of eight cases
Etches, R. C. (1994) · Canadian Journal of Anaesthesia · doi:10.1007/bf03009805 · Cited by 222 · cited 2×
“This may be illustrated in more detail by referring to a review of a database of approximately 1,600 PCA patients in Canada.(30) Eight patients (approximately 0.”
BackgroundInfluentialCLINICAL ACTIONS OF FENTANYL AND BUPRENORPHINE
BOAS, R. A., & VILLIGER, J. W. (1985) · British Journal of Anaesthesia · doi:10.1093/bja/57.2.192 · Cited by 212 · cited 1×
“(#6 h).(59,60) Unlike for the opioids discussed so far in this”
BackgroundLutfy, K., Eitan, S., Bryant, C. D., Yang, Y. C., Saliminejad, N., Walwyn, W., Kieffer, B. L., Takeshima, H., Carroll, F. I., Maidment, N. T., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10331.2003 · Cited by 211 · cited 1×
“Alternatively, antagonism of the action of buprenorphine at other opioid receptors, such as the opioid receptor-like 1 receptor, have been postulated.(63)”
BackgroundPostoperative Epidural Morphine Is Safe on Surgical Wards
Ready, L. B., Loper, K. A., Nessly, M., & Wild, L. (1991) · Anesthesiology · doi:10.1097/00000542-199109000-00012 · Cited by 211 · cited 1×
“tively.(23,24) In 1,100 patients receiving opioids intrathecally, 0.”
BackgroundA Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia
Goff, D. C., Leahy, L., Berman, I., Posever, T., Herz, L., Leon, A. C., Johnson, S. A., & Lynch, G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00005 · Cited by 209
Pharmacokinetic–Pharmacodynamic Modeling of Opioids
Lötsch, J. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.01.012 · Cited by 207 · cited 2×
“Incidentally, but important when constructing pharmacokinetic or pharmacodynamic models, the plasma effect-site transfer half-lives (t1⁄2ke0) for fentanyl and its analogs are also short (5–15 min, depending on the measured endpoint), whereas morphine is much longer (2–3 h).(46) In vivo, therefore, the concentration of…”
BackgroundCui, Y., Liao, X.-X., Liu, W., Guo, R.-X., Wu, Z.-Z., Zhao, C.-M., Chen, P.-X., & Feng, J.-Q. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.07.014 · Cited by 206
Acute Pulmonary Edema Following Naloxone Reversal of High-dose Morphine Anesthesia
Flacke, J. W., Flacke, W. E., & Williams, G. D. (1977) · Anesthesiology · doi:10.1097/00000542-197710000-00009 · Cited by 206 · cited 1×
“The vasoconstriction may lead to a fluid shift from the systemic circulation to the pulmonary vascular bed, resulting in pulmonary edema.(64) When naloxone is titrated to effect, it is generally safe.”
BackgroundPRESENT STATE OF EXTRADURAL AND INTRATHECAL OPIOID ANALGESIA IN SWEDEN
RAWAL, N., ARNÉR, S., GUSTAFSSON, L. L., & ALLVIN, R. (1987) · British Journal of Anaesthesia · doi:10.1093/bja/59.6.791 · Cited by 203 · cited 2×
“tively.(23,24) In 1,100 patients receiving opioids intrathecally, 0.”
BackgroundSerotonin receptors: guardians of stable breathing
Richter, D. W., Manzke, T., Wilken, B., & Ponimaskin, E. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.10.010 · Cited by 196
THE FIRST YEAR'S EXPERIENCE OF AN ACUTE PAIN SERVICE
WHEATLEY, R. G., MADEJ, T. H., JACKSON, I. J. B., & HUNTER, D. (1991) · British Journal of Anaesthesia · doi:10.1093/bja/67.3.353 · Cited by 185
Hutchinson, M. R., Northcutt, A. L., Chao, L. W., Kearney, J. J., Zhang, Y., Berkelhammer, D. L., Loram, L. C., Rozeske, R. R., Bland, S. T., Maier, S. F., et al. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.008 · Cited by 180 · cited 3×
“Furthermore, using full body plethysmography and pulse oximetry, minocycline was shown to attenuate the respiratory depressant effects of morphine on measures such as tidal volume, minute volume, inspiratory and expiratory forces, and blood oxygen saturation, although minocycline did not affect respiratory rate.(113)…”
BackgroundInfluentialNaloxone treatment in opioid addiction: the risks and benefits
van Dorp, E. L., Yassen, A., & Dahan, A. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.125 · Cited by 179 · cited 1×
“Fortunately, perhaps, the commonly used opioid-receptor antagonist naloxone provides a good standard safety cover for reversal of opioid-induced respiratory depression.(9) However, with the intensity and duration of the respiratory depressant effects dependent on the pharmacological characteristics and dose of the adm…”
BackgroundSelf-citationBlack, M. D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2065-6 · Cited by 174 · cited 1×
“taminergic function, such as cognitive disorders, attention deficit hyperactivity disorder, and schizophrenia.(97,98) This”
BackgroundSafety assessment of postoperative pain management by an acute pain service
Schug, S. A., & Torrie, J. J. (1993) · Pain · doi:10.1016/0304-3959(93)90016-i · Cited by 159
Glutamate-based therapeutic approaches: ampakines
LYNCH, G. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.09.005 · Cited by 158 · cited 1×
“taminergic function, such as cognitive disorders, attention deficit hyperactivity disorder, and schizophrenia.(97,98) This”
BackgroundDahan, A., Sarton, E., Teppema, L., Olievier, C., Nieuwenhuijs, D., Matthes, H. W. D., & Kieffer, B. L. (2001) · Anesthesiology · doi:10.1097/00000542-200105000-00021 · Cited by 150 · cited 2×
“There is ample evidence that opioid analgesics interact with ventilatory control, causing some degree of respiratory depression.(7,8,114,115) However, opioid treatment of moderate to severe pain is generally safe with about 0.”
BackgroundSelf-citationSertuerner (1817) · Annalen der Physik · doi:10.1002/andp.18170550104 · Cited by 148
Influence of anaesthesia and analgesia on the control of breathing
Dahan, A., & Teppema, L. J. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg150 · Cited by 142 · cited 2×
“altered before the patient’s arterial carbon dioxide concentration rises sufficiently to sustain ventilatory drive.(17,53,54)”
BackgroundSelf-citationOsterwalder, J. J. (1996) · Journal of Toxicology: Clinical Toxicology · doi:10.3109/15563659609013811 · Cited by 137 · cited 1×
“3%) suffered complications such as cardiac arrest, pulmonary edema, and epileptic seizures,(69) with the primary cause of cardiorespiratory complications from naloxone being a massive release of catecholamines.(69) When naloxone is given to a patient who is hypovolemic, hypotensive, and/or previously (before opioid tr…”
BackgroundA Dose-Response Study of Intrathecal Morphine: Efficacy, Duration, Optimal Dose, and Side Effects
Jacobson, L., Chabal, C., & Brody, M. C. (1988) · Anesthesia & Analgesia · doi:10.1213/00000539-198811000-00011 · Cited by 131
McQuay, & Moore (1998) · Health Technology Assessment · doi:10.3310/hta2120 · Cited by 131 · cited 1×
“6% and placebo 2%).(19) Absence, or very low incidence, of respiratory depression with single or repeated doses of intramuscular morphine (10 mg) is a common finding of postoperative studies, exemplified by a very recent study in which a 10-mg dose of morphine was compared on intramuscular and intravenous administrati…”
BackgroundBallanyi, K., Lalley, P. M., Hoch, B., & Richter, D. W. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.127bf.x · Cited by 130 · cited 2×
“5HT4a agonists do not influence opioid-induced analgesia because 5HT4a receptors are absent from pain-processing regions.(94) Stimulation of 5HT4a receptors in the pre-Bötzinger complex in rats by the agonist BIMU8 has been shown to protect spontaneous respiratory activity and to reduce or abolish fentanylinduced resp…”
BackgroundNaloxone Reversal of Buprenorphine-induced Respiratory Depression
van Dorp, E., Yassen, A., Sarton, E., Romberg, R., Olofsen, E., Teppema, L., Danhof, M., & Dahan, A. (2006) · Anesthesiology · doi:10.1097/00000542-200607000-00012 · Cited by 129 · cited 8×
“underlying disease, pain and the state of arousal, genetic make-up of the patient, and exogenous stimulatory factors.(41) It is, therefore, important to understand the pharmacokinetics and pharmacodynamics of the specific opioid agonist, antagonist, and their interactions for effective and safe reversal of opioid-indu…”
BackgroundMethodInfluentialSelf-citationThe safety and utilization of patient-controlled analgesia
Sidebotham, D. A., Dijkhuizen, M. R. J., & Schug, S. A. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00182-6 · Cited by 127 · cited 3×
“5 mg.(31) The incidence of respiratory depression after the use of morphine PCA is often reported as associated with the use of higher doses of opiate when trying to achieve pain relief (or overdose error in PCA use).”
BackgroundResultAmpakine CX717 Protects against Fentanyl-induced Respiratory Depression and Lethal Apnea in Rats
Ren, J., Ding, X., Funk, G. D., & Greer, J. J. (2009) · Anesthesiology · doi:10.1097/aln.0b013e31819faa2a · Cited by 122 · cited 2×
“7).(106,107) Hence, in the rat, the ampakines CX546 and”
BackgroundMethodNaloxone reversal of buprenorphine-induced respiratory depression
Gal, T. J. (1989) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1989.10 · Cited by 122
POSTOPERATIVE HYPOXAEMIA: COMPARISON OF EXTRADURAL, I.M. AND PATIENT-CONTROLLED OPIOID ANALGESIA
Wheatley, R. G., Somerville, I. D., Sapsford, D. J., & Jones, J. G. (1990) · British Journal of Anaesthesia · doi:10.1093/bja/64.3.267 · Cited by 121
Pierrefiche, O., Schwarzacher, S. W., Bischoff, A. M., & Richter, D. W. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.245bo.x · Cited by 116
Benzamide-Type AMPA Receptor Modulators Form Two Subfamilies with Distinct Modes of Action
Arai, A., Xia, Y., Rogers, G. A., LYNCH, G. S., & Kessler, M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040360 · Cited by 113 · cited 1×
“accelerates channel opening, whereas CX546 primarily slows channel closing.(102) CX546 binds to the AMPA receptor”
BackgroundAmpakines Alleviate Respiratory Depression in Rats
Ren, J., Poon, B. Y., Tang, Y., Funk, G. D., & Greer, J. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200606-778oc · Cited by 111
Michaelis, L. L., Hickey, P. R., Clark, T. A., & Dixon, W. M. (1974) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)64408-6 · Cited by 98
Romberg, R. R., Sarton, E. Y., Teppema, L. J., Matthes, H. W. D., Kieffer, B. L., & Dahan, A. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg279 · Cited by 97
Self-citation5‐HT‐1A receptor‐mediated modulation of medullary expiratory neurones in the cat.
Lalley, P. M., Bischoff, A. M., & Richter, D. W. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020116 · Cited by 94
Arai, A., Xia, Y., & Suzuki, É. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.033 · Cited by 88
Yassen, A., Olofsen, E., van Dorp, E., Sarton, E. Y., Teppema, L. J., Danhof, M., & Dahan, A. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746110-00004 · Cited by 86 · cited 6×
“A pharmacokinetic-pharmacodynamic model of buprenorphine-induced respiratory depression by naloxone has been developed.(45) For buprenorphine, the t1⁄2ke0 was 75 min in the presence of naloxone, demonstrating a similar value to that derived previously in the absence of naloxone.”
BackgroundMethodResultInfluentialSelf-citationMechanism and impact of allosteric AMPA receptor modulation by the AmpakineTM CX546
Nagarajan, N., Quast, C., Boxall, A. R., Shahid, M., & Rosenmund, C. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00133-2 · Cited by 86
Mu Opioid Receptor Antagonists: Recent Developments
Goodman, A. J., Bourdonnec, B. L., & Dolle, R. E. (2007) · ChemMedChem · doi:10.1002/cmdc.200700143 · Cited by 84
Cole, P. J., Craske, D., & Wheatley, R. G. (2000) · British Journal of Anaesthesia · doi:10.1093/bja/85.2.233 · Cited by 83
Sahibzada, N., Ferreira, M. A. R., Wasserman, A. M., Taveira‐DaSilva, A. M., & Gillis, R. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35342-x · Cited by 83
Naloxone for Antagonism of Morphine-Induced Respiratory Depression
Longnecker, D. E., GRAZIS, P. A., & Eggers, G. W. N. (1973) · Anesthesia & Analgesia · doi:10.1213/00000539-197305000-00033 · Cited by 83
Hypertensive Reaction to Naloxone
Tanaka, G. Y. (1974) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1974.03230260019008 · Cited by 81
Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist
Wilken, B., Lalley, P. M., Bischoff, A. M., Christen, H. ‐., Behnke‐Mursch, J., Hanefeld, F. A., & Richter, D. W. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70315-9 · Cited by 79 · cited 1×
“modeling with the available data on buspirone, concluded that, in this study, the effect-site concentrations of buspirone achieved in the brain were lower than those estimated in studies with rats.(88) The inability of buspirone to reverse morphine-induced respiratory depression, therefore, may be due to inadequate bu…”
ResultFleming, B. M., & Coombs, D. W. (1992) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(92)90132-2 · Cited by 78 · cited 2×
“%) were reported with severe respiratory depression of less than 8 breaths/min, 5 of which had received a bolus dose of morphine of 2 or 2.5 mg.31 The incidence of respiratory depression after the use of morphine PCA is often reported as associated with the use of higher doses of opiate when trying to achieve pain rel…”
ResultInfluentialFatal Respiratory Depression after??Multiple Intravenous Morphine Injections
L??tsch, J., Dudziak, R., Freynhagen, R., Marschner, J., & Geißlinger, G. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00001 · Cited by 77 · cited 2×
“There is ample evidence that opioid analgesics interact with ventilatory control, causing some degree of respiratory depression.(7,8,114,115) However, opioid treatment of moderate to severe pain is generally safe with about 0.”
BackgroundAntagonism by naloxone of narcotic-induced respiratory depression and analgesia.
McGilliard, K. L., & Takemori, A. E. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31446-1 · Cited by 77 · cited 2×
“In mice, after subcutaneous administration of [(3)H]naloxone, the naloxone concentration in the whole brain was related to the dose administered (and unaffected by the simultaneous administration of morphine) and evenly distributed across the four brain areas examined (pons-medulla, cerebellum, midbrain, and cerebral…”
BackgroundNucleus raphe obscurus evokes 5-HT-1A receptor-mediated modulation of respiratory neurons
Lalley, P. M., Beňačka, R., Bischoff, A. M., & Richter, D. W. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01233-4 · Cited by 75
Pulmonary Edema Following Naloxone Administration in a Patient Without Heart Disease
Taff, R. H. (1983) · Anesthesiology · doi:10.1097/00000542-198312000-00019 · Cited by 75
[3H]Alvimopan binding to the μ opioid receptor: Comparative binding kinetics of opioid antagonists
Cassel, J. A., Daubert, J. D., & DeHaven, R. N. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.008 · Cited by 74
A Model of the Ventilatory Depressant Potency of Remifentanil in the Non–steady State
Bouillon, T. W., Bruhn, J., Radu‐Radulescu, L., Andresen, C., Cohane, C. A., & Shafer, S. L. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00007 · Cited by 74 · cited 1×
“altered before the patient’s arterial carbon dioxide concentration rises sufficiently to sustain ventilatory drive.(17,53,54)”
BackgroundNaloxone for antagonism of morphine-induced respiratory depression.
Longnecker, D. E., GRAZIS, P. A., & Eggers, G. W. N. (1973) · PubMed · Cited by 73
Influences of Morphine on the Ventilatory Response to Isocapnic Hypoxia
Berkenbosch, A., Teppema, L. J., Olievier, C. N., & Dahan, A. (1997) · Anesthesiology · doi:10.1097/00000542-199706000-00016 · Cited by 71
Self-citationHanna, M., Elliott, K. M., & Fung, M. (2005) · Anesthesiology · doi:10.1097/00000542-200504000-00018 · Cited by 68 · cited 1×
“For example, in a randomized, double-blinded comparison of morphine and morphine-6-glucuronide administered subcutaneously by PCA after orthopedic surgery, 14 of 48 (29%) patients receiving PCA morphine (2-mg bolus doses with a lockout of 10 min) had respiratory rates that decreased below 8 breaths/min at one or more…”
MethodPulmonary Edema Following Low-dose Naloxone Administration
Partridge, B. L., & Ward, C. F. (1986) · Anesthesiology · doi:10.1097/00000542-198612000-00037 · Cited by 66
Serotonin 1A Receptor Agonists Reverse Respiratory Abnormalities in Spinal Cord-Injured Rats
Teng, Y. D., Bingaman, M. T., Taveira‐DaSilva, A. M., Pace, P. P., Gillis, R. A., & Wrathall, J. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04182.2003 · Cited by 62
Oertel, B. G., Schneider, A., Rohrbacher, M., Schmidt, H., Tegeder, I., Geisslinger, G., & Lötsch, J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100018 · Cited by 59 · cited 2×
“However, higher doses of buspirone were contraindicated because, in the healthy volunteers, buspirone (60 mg) significantly increased morphine-induced nausea.(91) Therefore, buspirone would not seem to be an adequate clinical tool to treat opioidinduced respiratory depression or to explore 5HT1A mechanisms in man.”
BackgroundAmin, H. M., Sopchak, A. M., Esposito, B., Henson, L., Batenhorst, R. L., Fox, A. W., & Camporesi, E. M. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10604-6 · Cited by 58 · cited 4×
“The two possible explanations of this lack of reversibility of remifentanil by naloxone discussed are (1) even the low-dose infusion maintained a concentration of remifentanil at the receptor level that the (fixed) dose of naloxone was unable to displace or (2) the thermodynamics of the remifentanil—receptor interacti…”
BackgroundInfluentialTveita, T., Thoner, J., Klepstad, P., Dale, O., Jystad, Å., & Borchgrevink, P. C. (2008) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2008.01608.x · Cited by 55
Intrathecal morphine for the relief of post‐hysterectomy pain ‐ a double‐blind, dose‐response study
Sarma, V. J., & Boström, U. V. (1993) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1993.tb03705.x · Cited by 54 · cited 1×
“Epidural and intrathecal administration of opioids was shown in the 1980s and 1990s to provide effective and long-lasting postoperative analgesia, and the use of low-dose opioids was advocated.(21,22) In two large reviews of more than 14,000 and 11,000 patients receiving opioids extradurally, with the majority being a…”
BackgroundAn acute pain service in an Australian teaching hospital: the first year
Macintyre, P. E., Runciman, W. B., & Webb, R. K. (1990) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb125503.x · Cited by 51
LOTSCH, J., SKARKE, C., SCHNEIDER, A., HUMMEL, T., & GEISSLINGER, G. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.05.010 · Cited by 51 · cited 2×
“To investigate the potential clinical benefits of 5HT4a agonists in man, the 5HT4a agonist mosapride has been investigated in a double-blinded, crossover study in healthy volunteers.(95) Twelve healthy volunteers received oral doses of mosapride (5 mg daily for 5 days), and on the day of testing, three doses of mosapr…”
ResultEarly Respiratory Depression Resistant to Naloxone Following Epidural Buprenorphine
Knape, J. T. A. (1986) · Anesthesiology · doi:10.1097/00000542-198603000-00018 · Cited by 50
Meyer, L. C. R., Fuller, A., & Mitchell, D. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00440.2005 · Cited by 50 · cited 1×
“In another species, the goat, an alternative 5HT4a agonist, zacopride, reversed etorphine-induced respiratory depression without affecting immobilization or sedation.(76) The functional antagonism of opioids and 5HT4a agonists on rhythms in the pre-Bötzinger complex are thought to be due to convergence of neuronal sig…”
BackgroundMadej, T. H., Wheatley, R. G., Jackson, I., & HUNTER, D. (1992) · British Journal of Anaesthesia · doi:10.1093/bja/69.6.554 · Cited by 47
Sedation for the critically ill
Sydow, M., & Neumann, P. (1999) · Intensive Care Medicine · doi:10.1007/s001340050917 · Cited by 47 · cited 1×
“to patients, and excessive sedation may contribute to increased morbidity and mortality.(1,2) However, it is perhaps respiratory”
BackgroundReversal of Morphine Anesthesia with Naloxone
Johnstone, R. E., Jobes, D. R., Kennell, E. M., Behar, M. G., & Smith, T. C. (1974) · Anesthesiology · doi:10.1097/00000542-197410000-00010 · Cited by 45
Self-citationWheatley, R. G., Shepherd, D., Jackson, I., Madej, T. H., & HUNTER, D. (1992) · British Journal of Anaesthesia · doi:10.1093/bja/69.6.558 · Cited by 45
The isolation of morphine--first principles in science and ethics.
Huxtable, R. J., & Schwarz, S. K. W. (2001) · PubMed · Cited by 44
Buspirone in Rett syndrome respiratory dysfunction
Andaku, D. K., Mercadante, M. T., & Schwartzman, J. S. (2005) · Brain and Development · doi:10.1016/j.braindev.2004.09.011 · Cited by 44
Animal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine
Yassen, A., Olofsen, E., Kan, J., Dahan, A., & Danhof, M. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746050-00005 · Cited by 41 · cited 1×
“This slow equilibration is paralleled by slow receptor association/dissociation kinetics (t1⁄2koff " 70 min).(45,62) The kinetic values for buprenorphine are in marked contrast to the rapid kinetics displayed by naloxone (t1⁄2koff " 0.”
BackgroundSelf-citationBuprenorphine-The Unique Opioid Analgesic: Pharmacology and Clinical Application
Budd, K., Raffa, R. B., Dahan, A., Cowan, A., Foley, K. M., Friedrichs, E., Glynn, C. J., Hans, G. H., Kress, H. G., Mercadante, S., et al. (2007) · Cited by 41
Self-citationGuenther, U., Manzke, T., Wrigge, H., Dutschmann, M., Zinserling, J., Putensen, C., & Hoeft, A. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318198f828 · Cited by 38
Gross, J. B. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00002 · Cited by 37
Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains
Yamauchi, M., Dostal, J., Kimura, H., & Strohl, K. P. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00069.2008 · Cited by 35
Bytnerowicz, A., Arbaugh, M. J., Schilling, S. L., Frączek, W., Alexander, D., & Dawson, P. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.57 · Cited by 35
Metabolism and pharmacokinetics of naloxone.
Weinstein, S. H., Pfeffer, M., & Schor, J. M. (1973) · PubMed · Cited by 32
Sarton, E. Y., Teppema, L. J., & Dahan, A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73693-8_85 · Cited by 32 · cited 2×
“4 mg).(47) However, reversal of morphine was short lived with a rapid return to full respiratory depression (renarcotization after 30 min), as shown in figure 3.”
BackgroundSelf-citationBuspirone Treatment for Apneustic Breathing in Brain Stem Infarct
El‐Khatib, M. F., Kiwan, R. A., & Jamaleddine, G. W. (2003) · Respiratory Care · doi:10.4187/respcare.03480956 · Cited by 29
Morphine overdose from error propagation on an acute pain service
Syed, S., Paul, J., Hueftlein, M., Kampf, M., & McLean, R. F. (2006) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03021849 · Cited by 28 · cited 1×
“The incidence of respiratory depression after the use of morphine PCA is often reported as associated with the use of higher doses of opiate when trying to achieve pain relief (or overdose error in PCA use).(31,32) In agreement with this, there are also several studies demonstrating a higher incidence of patient respi…”
ResultComparison of Remifentanil and Fentanyl for Postoperative Pain Control after Abdominal Hysterectomy
Choi, S. H., Koo, B., Nam, S. H., Lee, S. J., Kim, K. J., Kil, H. K., Lee, K., & Jeon, D. H. (2008) · Yonsei Medical Journal · doi:10.3349/ymj.2008.49.2.204 · Cited by 28 · cited 1×
“7%), and the study was closed.(52) No events of serious respiratory depression were observed in the fentanyl group (0.”
BackgroundTakahashi, M., Sugiyama, K., Hori, M., Chiba, S., & 日下, 潔. (2004) · Journal of Anesthesia · doi:10.1007/s00540-003-0214-4 · Cited by 27 · cited 1×
“This strategy has been expanded more recently to investigate whether infusions of naloxone could be titrated in an up-and-down manner to maintain adequate spontaneous respiration after high-dose fentanyl anesthesia.(50) Patients (n " 59) scheduled for elective surgery for visceral cancer received an infusion of fentan…”
BackgroundWang, X., Dergacheva, O., Kamendi, H., Gorini, C., & Mendelowitz, D. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091033 · Cited by 27 · cited 1×
“, including an influence on related and interacting components such as the cardiovascular system.(77) One difficulty in interpreting the effects of 5HT ligands in terms of actions at individual 5HT receptors is frequently that many of the ligands available do not demonstrate a high enough degree of selectivity to enab…”
BackgroundPellerin, L., & Magistretti, P. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02905.x · Cited by 26 · cited 1×
“Minocycline, a Microglial Inhibitor A further action of the ampakine CX546 is the enhancement of astrocyte metabolism, which increases glucose use and lactate production and may play some role in cognition enhancement.(109) With regard to respiratory depression, however, the action of opioids on immune cells such as a…”
BackgroundPartial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.
Zuurmond, W. W. A., Meert, T. F., & Noorduin, H. (2002) · PubMed · Cited by 25
Kaufman, R. D., Gabathuler, M. L., & Bellville, J. W. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32774-6 · Cited by 25 · cited 1×
“Naloxone inhibits all pharmacological effects of opioids and, in line with classic receptor theory, produces a parallel right shift in the dose-response curves of opioids.(39) Naloxone is readily absorbed after oral administration, but its low bioavailability makes naloxone less suitable for this administration route.”
BackgroundDevelopmental changes of serotonin 4(a) receptor expression in the rat pre‐Bötzinger complex
Manzke, T., Preuße, S., Hülsmann, S., & Richter, D. W. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21581 · Cited by 22
Role of Brainstem Sodium/Proton Exchanger 3 for Breathing Control during Chronic Acid–Base Imbalance
Kiwull-Schöne, H., Kiwull, P., Frede, S., & Wiemann, M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-347oc · Cited by 21 · cited 1×
“There are other promising agents available that deserve study, for example, inhibitors of the sodium/proton exchanger type 3 (NHE3) that have a stimulatory effect on breathing due to an action within central respiratory pathways.(116,117)”
BackgroundMégarbane, B., Declèves, X., Bloch, V., Bardin, C., Chast, F., & Baud, F. J. (2007) · Critical Care · doi:10.1186/cc5150 · Cited by 20
COMPARISON BETWEEN HIGH-DOSE SUFENTANIL-OXYGEN AND HIGH-DOSE FENTANYL-OXYGEN FOR NEUROANAESTHESIA
Shupak, R. C., & Harp, J. R. (1985) · British Journal of Anaesthesia · doi:10.1093/bja/57.4.375 · Cited by 19
1 Basic Pharmacology of Buprenorphine
(2005) · Thieme eBooks · doi:10.1055/b-0034-14986 · Cited by 15
The NHE3 inhibitor AVE1599 stimulates phrenic nerve activity in the rat.
Wiemann, M., Piechatzek, L., Göpelt, K., Kiwull-Schöne, H., Kiwull, P., & Bingmann, D. (2008) · PubMed · Cited by 14
MEDIASTINAL PARATHYROID ADENOMA: Report of a Case with Unusual Fatal Course
STAUB, W. (1950) · Archives of Internal Medicine · doi:10.1001/archinte.1950.00230110040003 · Cited by 14
Cited by
Poorly controlled postoperative pain: prevalence, consequences, and prevention
Gan, T. J. (2017) · Journal of Pain Research · doi:10.2147/jpr.s144066 · Cited by 1,489
Turner, P. V., Brabb, T., Pekow, C. A., & Vasbinder, M. A. (2011) · PubMed · Cited by 1,324
Hah, J. M., Bateman, B. T., Ratliff, J., Curtin, C., & Sun, E. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002458 · Cited by 728
A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs
Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000034 · Cited by 488
“Copyright C© 2014 American Society of Addiction Medicine ISSN: 1932-0620/14/0803-0153 DOI: 10.1097/ADM.0000000000000034 and prevents fatalities (Buajordet et al., 2004; Clarke et al., 2005; Dahan et al., 2010; Boyer, 2012).”
BackgroundInfluentialA review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Metadata
- Authors
- Dahan, A., Aarts, L., & Smith, T. W.
- Affiliations
- Leiden University Medical Center (NL)
- Clinical Pharmacologist, North Yorkshire, United Kingdom.
- ORCID
- Dahan, Albert
- Venue
- Anesthesiology
- Published
- 2010-01-01
- Volume
- 112
- Issue
- 1
- Pages
- 226-238
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2132468342
- Cited by
- 634
- References
- 114
- Citations by year
- 2026: 30 · 2025: 34 · 2024: 38 · 2023: 31 · 2022: 58 · 2021: 57 · 2020: 59 · 2019: 53 · 2018: 37 · 2017: 43 · 2016: 35 · 2015: 39 · 2014: 30 · 2013: 35 · 2012: 21
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesiology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid-induced respiratory depression, naloxone, naloxone reversal, opioid receptor affinity, receptor kinetics, opioid analgesia, serotonergic agonists, ampakines, minocycline
- MeSH terms
- Buprenorphine, Humans, Minocycline, Naloxone, Narcotic Antagonists, Postoperative Complications, Respiratory Insufficiency, Serotonin Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.